# Decisio Health

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/decisio-health

- Industry: Software
- Headquarters: Houston, US
- Website: www.decisiohealth.com
- Total disclosed funding: $4.5M
- Latest round: Series A (May 18, 2016)
- Investors on record: 2

## About

Decisio Health, Inc. is a healthcare technology company focused on enhancing clinical decision-making through advanced analytics and data integration solutions, aiming to improve patient outcomes in healthcare settings.Decisio Health, Inc. develops innovative solutions for healthcare analytics and decision support. Founded in 2013, the company is headquartered in Houston, US. The founders, Gray Hancock and Joel Watts, have a background in healthcare technology. In January 2025, Decisio Health was acquired by AirStrip Technologies, Inc., a move aimed at broadening their customer base and enhancing their product platform. The company has successfully completed 6 funding deals, with the latest being a Series B round that raised USD 3.60 mn, bringing their total funding to USD 3.60 mn.Decisio Health offers advanced solutions for clinical surveillance, decision support, and alarm management, integrating clinical data into a cohesive platform for real-time decision-making. Their products include comprehensive patient monitoring systems tailored for obstetrics and cardiology, facilitating remote access to critical patient data for healthcare professionals and improving patient outcomes through timely interventions.Decisio Health generates revenue primarily through subscription-based models for its clinical surveillance and alarm management solutions. Healthcare institutions subscribe to access a suite of services, including remote patient monitoring and alarm analytics, with structured agreements covering licensing fees for software, support, and updates. This model allows for continuous engagement with clients and a steady revenue stream from ongoing contracts.Decisio Health plans to leverage its recent acquisition by AirStrip Technologies to enhance its platform and expand into new markets. The focus will be on developing upcoming products that cater to emerging needs in healthcare analytics. This strategic direction is expected to be supported by the recent Series B funding, allowing for the exploration of new geographic regions and customer segments. The acquisition, finalized in January 2025, positions Decisio Health to significantly broaden its market outreach.

## Funding rounds

- Series A, May 18, 2016, $4.5M — UT Horizon Fund, Declatex, LLC

## Investors

- UT Horizon Fund (https://capitalatlas.ai/funds/ut-horizon-fund) — Series A
- Declatex, LLC — Series A